Concepedia

Allan Lipton

AL

Statistics

Publications

8

Citations

1.5K

H-Index

8

Active since

1987

Affiliations

Penn State Milton S. Hershey Medical Center(Current)

Novartis (Switzerland)

Pennsylvania State University

Novartis (United States)

Allan Lipton is an author at Penn State Milton S. Hershey Medical Center specializing in oncology, medicine, and metastatic breast cancer.

Publications per year

1987–2018

8

Publications

8

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

Allan Lipton, Richard L. Theriault, Gabriel N. Hortobagyi et al. · Cancer · 2000 · 673 citations

Medicine, Oncology, Pharmacotherapy +17

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

James R. Berenson, Lee S. Rosen, Anthony Howell et al. · Cancer · 2001 · 532 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody

Lois Witters, Rakesh Kumar, Vernon M. Chinchilli et al. · Breast Cancer Research and Treatment · 1997 · 92 citations

Medicine, Cancer Biology, Oncology +14

Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer

Andrea Manni, Alice E. Boucher, L. M. Demers et al. · Breast Cancer Research and Treatment · 1989 · 69 citations

Medicine, Endocrinology, Oncology +16

A phase I trial of CGS 16949a. A new aromatase inhibitor

Allan Lipton, Harold A. Harvey, Laurence M. Demers et al. · Cancer · 1990 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 8